Splicing defects the ataxia-telangiectasia gene, ATM: Underlying mutations and consequences

American Journal of Human Genetics

Volumn 64, Issue 6, 1999, Pages 1617-1631

  Teraoka, Sharon N ^a   Telatar, Milhan ^b   Becker Catania, Sara ^b   Liang, Teresa ^b   Önengüt, Suna ^c   Tolun, Asli ^c   Chessa, Luciana ^d   Sanal, Özden ^e   Bernatowska, Eva ^g   Gatti, Richard A ^b   Concannon, Patrick ^a,f  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BOGAZICI UNIVERSITY   (Turkey)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e HACETTEPE UNIVERSITY   (Turkey)

^f BENAROYA RESEARCH INSTITUTE   (United States)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATAXIA TELANGIECTASIA; CONSENSUS SEQUENCE; EXON; GENE MUTATION; HUMAN; INTRON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RNA SPLICING; SEQUENCE ANALYSIS; SILENT GENE;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0039108539     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302418     Document Type: Article

References (42)

1. Aoufouchi S, Yelamos J, Milstein C (1996) Nonsense mutations inhibit RNA splicing in a cell-free system: recognition of mutant codon is independent of protein synthesis. Cell 85:415-422
2. Athma P, Rappaport R, Swift M (1996) Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92:130-134
3. Beaudet AL, Tsui LC (1993) A suggested nomenclature for designating mutations. Hum Mutat 2:245-248
4. Belgrader P, Maquat LE (1994) Nonsense but not missense mutations can decrease the abundance of nuclear mRNA for the mouse major urinary protein, while both types of mutations can facilitate exon skipping. Mol Cell Biol 14:6326-6336
5. Chen G, Lee EY-HP (1996) The product of the ATM gene is a 370-kDa nuclear phosphoprotein. J Biol Chem 271:33693-33697
6. Concannon P, Gatti RA (1997) Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia. Hum Mutat 10:100-107
7. Cooper TA, Mattox W (1997) The regulation of splice-site selection, and its role in human disease. Am J Hum Genet 61:259-266
8. Fresno: a phenotype linking ataxia-telangiectasia with the Nijmegen breakage syndrome. Am J Hum Genet 45:270-275
9. Dietz HC, Valle D, Francomano CA, Kendzior RJ Jr, Pyeritz RE, Cutting G (1993) The skipping of constitutive exons in vivo induced by nonsense mutations. Science 259:680-683
10. Dork T, Westermann S, Dittrich O, Twardowski M, Karstens JH, Schmidtke J, Stuhrmann M (1997) A frequent polymorphism of the gene mutated in ataxia telangiectasia. Mol Cell Probes 11:71-73
11. Easton DF (1994) Cancer risks in A-T heterozygotes. Int J Radiat Biol 66:S177-S182
12. FitzGerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, et al (1997) Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 15:307-310
13. Gatti RA (1991) Localizing the genes for ataxia-telangiectasia: a human model for inherited cancer susceptibility. Adv Cancer Res 56:77-104
14. _ (1998) Ataxia-telangiectasia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th ed. McGraw-Hill, New York
15. Gilad S, Chessa L, Khosravi R, Russell P, Galanty Y, Piane M, Gatti RA, et al (1998) Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am J Hum Genet 62:551-561
16. Gilad S, Khosravi R, Shkedy D, Uziel T, Ziv Y, Savitsky K, Rotman G, et al (1996) Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet 5:433-439
17. Hoffmeyer S, Nürnberg P, Ritter H, Fahsold R, Leistner W, Kaufmann D, Krone W ( 1998) Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors. Am J Hum Genet 62:269-277
18. Hull J, Shackleton S, Harris A (1994) The stop mutation R553X in the CFTR gene results in exon skipping. Genomics 19:362-364
19. Huo YK, Wang Z, Hong J-H, Chessa L, McBride WH, Perlman SL, Gatti RA (1994) Radiosensitivity of ataxia-telangiectasia, X-linked agammaglobulinemia, and related syndromes using a modified colony survival assay. Cancer Res 54:2544-2547
20. Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41-45
21. Lakin ND, Weber P, Stankovic T, Rottinghaus ST, Taylor AMR, Jackson SP (1996) Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene 13:2707-2716
22. Liu W, Qian C, Francke U (1997) Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome. Nat Genet 16:328-329
23. Maquat LE (1995) When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. RNA 1:453-465
24. _ (1996) Defects in RNA splicing and the consequence of shortened translational reading frames. Am J Hum Genet 59:279-286
25. Mazoyer S, Puget N, Perrin-Vidoz L, Lynch HT, Serova-Sinilnikova OM, Lenoir GM (1998) A BRCA1 nonsense mutation causes exon skipping. Am J Hum Genet 62:713-715
26. McConville CM, Stankovic T, Byrd PJ, McGuire GM, Yao Q-Y, Lennox GG, Taylor AMR (1996) Mutations associated with variant phenotypes in ataxia-telangiectasia. Am J Hum Genet 59:320-330
27. Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879.
28. Padgett RA, Grabowski PJ, Konarska MM, Seiler S, Sharp PA (1986) Splicing of messenger RNA precursors. Annu Rev Biochem 55:1119-1150
29. Ruttledge MH, Andermann AA, Phelan CM, Claudio JO, Han F-y, Chretien N, Rangaratnam S, et al (1996) Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet 59:331-342
30. Savitsky K, Bar-Shiva A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, et al (1995a) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753
31. Savitsky K, Platzer M, Uziel T, Gilad S, Sartiel A, Rosenthal A, Elroy-Stein O, et al (1997) Ataxia-telangiectasia: structural diversity of untranslated sequences suggests complex post-transcriptional regulation of ATM gene expression. Nucleic Acids Res 25:1678-1684
32. Savitsky K, Sfez S, Tagle DA, Ziv Y, Sartiel A, Collins FS, Shiloh Y, et al (1995b) The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 4:2025-2032
33. Schwarze U, Goldstein JA, Byers PH (1997) Splicing defects in the COL3A1 gene: marked preference for 5′ (donor) splice-site mutations in patients with exon-skipping mutations and Ehlers-Danlos syndrome type IV. Am J Hum Genet 61:1276-1286
34. Shapiro MB, Senapathy P (1987) RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 15:7155-7174
35. Stankovic T, Kidd AMJ, Sutcliffe A, McGuire GM, Robinson P, Weber P, Bedenham T, et al (1998) ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 62:334-345
36. Steingrimsdottir H, Rowley G, Dorado G, Cole J, Lehmann AR (1992) Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene. Nucleic Acids Res 20:1201-1208
37. Swift M, Morrell D, Massey RB, Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325:1831-1836
38. Telatar M, Teraoka S, Wang Z, Chun HH, Liang T, Castellvi-Bel S, Udar N, et al (1998) Ataxia-telangiecrasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations. Am J Hum Genet 62:86-97
39. Telatar M, Wang Z, Udar N, Liang T, Bernatowska-Matuszkiewicz E, Lavin M, Shiloh Y, et al (1996) Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening. Am J Hum Genet 59:40-44
40. Uziel T, Savitsky K, Platzer M, Ziv Y, Helblitz T, Nehls M, Boehm T, et al (1996) Genomic organization of the ATM gene. Genomics 33:317-320
41. Vorechovsky I, Rasio D, Luo L, Monaco C, Hammarstrom L, Webster ADB, Zaloudik J, et al (1996) The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res 56:2726-2732
42. Wright J, Teraoka S, Önengüt S, Tolun A, Gatti RA, Ochs HD, Concannon P (1996) A high frequency of distinct ATM gene mutations in ataxia-telangiectasia. Am J Hum Genet 59:839-846